Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Sage Therapeutics to report topline data from mid-stage study of SAGE-217 in PPD in Q4 [Seeking Alpha]

Sage Therapeutics, Inc. (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
Company Research Source: Seeking Alpha
Sage Therapeutics to report topline data from mid-stage study of SAGE-217 in PPD in Q4Sage Therapeutics (NASDAQ:SAGE)reports that it expects to announce topline data from a Phase 2 clinical trial evaluating SAGE-217 in women with postpartum depression (PPD) in Q4.SAGE-217, a neuroactive steroid, is next-generation GABA modulator. The GABA system, the major inhibitory signaling pathway in the brain and central nervous system (NYSE:CNS), plays a key role in regulating CNS function.It also expects the $575M proceeds from its planned stock offering, along with cash on hand and expected sales from brexolone IV, to be sufficient to fund operations into 2020.Previously:Sage Therapeutics launches mid-stage study of SAGE-217 in PPD (Dec. 19, 2016)Click to subscribe to real-time analytics on CNSNow read:Cohen & Steers, Inc. 2017 Q4 - Results - Earnings Call Slides » Show less Read more
Impact Snapshot
Event Time:
SAGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
SAGE alerts

from News Quantified
Opt-in for
SAGE alerts

from News Quantified